Rimonabant T1519L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker t
CAS nr:
168273-06-1
Purity:
98%
Molecular Weight:
463,79
SMILES:
n1(nc(c(c1c1ccc(cc1)Cl)C)C(=O)NN1CCCCC1)c1c(cc(cc1)Cl)Cl
Formula:
C22H21Cl3N4O
Pathway:
Microbiology/Virology,Metabolism,Proteases/Proteasome,GPCR/G Protein
Target:
Antibacterial,Acyltransferase,Acyltransferase,Cannabinoid Receptor
